Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

The adenovirus E4-ORF3 protein stimulates SUMOylation of general transcription factor TFII-I to direct proteasomal degradation

Tools
- Tools
+ Tools

Bridges, Rebecca G., Sohn, Sook-Young, Wright, Jordan L., Leppard, Keith and Hearing, Patrick (2016) The adenovirus E4-ORF3 protein stimulates SUMOylation of general transcription factor TFII-I to direct proteasomal degradation. mBio, 7 (1). e02184-15. doi:10.1128/mBio.02184-15 ISSN 2150-7511.

[img]
Preview
PDF
WRAP_mBio-2016-Bridges-.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution.

Download (1879Kb) | Preview
Official URL: http://dx.doi.org/10.1128/mBio.02184-15

Request Changes to record.

Abstract

Modulation of host cell transcription, translation, and posttranslational modification processes is critical for the ability of many viruses to replicate efficiently within host cells. The human adenovirus (Ad) early region 4 open reading frame 3 (E4-ORF3) protein forms unique inclusions throughout the nuclei of infected cells and inhibits the antiviral Mre11-Rad50-Nbs1 DNA repair complex through relocalization. E4-ORF3 also induces SUMOylation of Mre11 and Nbs1. We recently identified additional cellular targets of E4-ORF3 and found that E4-ORF3 stimulates ubiquitin-like modification of 41 cellular proteins involved in a wide variety of processes. Among the proteins most abundantly modified in an E4-ORF3-dependent manner was the general transcription factor II–I (TFII-I). Analysis of Ad-infected cells revealed that E4-ORF3 induces TFII-I relocalization and SUMOylation early during infection. In the present study, we explored the relationship between E4-ORF3 and TFII-I. We found that Ad infection or ectopic E4-ORF3 expression leads to SUMOylation of TFII-I that precedes a rapid decline in TFII-I protein levels. We also show that E4-ORF3 is required for ubiquitination of TFII-I and subsequent proteasomal degradation. This is the first evidence that E4-ORF3 regulates ubiquitination. Interestingly, we found that E4-ORF3 modulation of TFII-I occurs in diverse cell types but only E4-ORF3 of Ad species C regulates TFII-I, providing critical insight into the mechanism by which E4-ORF3 targets TFII-I. Finally, we show that E4-ORF3 stimulates the activity of a TFII-I-repressed viral promoter during infection. Our results characterize a novel mechanism of TFII-I regulation by Ad and highlight how a viral protein can modulate a critical cellular transcription factor during infection.

Item Type: Journal Article
Subjects: Q Science > QH Natural history > QH301 Biology
R Medicine > RB Pathology
Divisions: Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- )
Library of Congress Subject Headings (LCSH): Adenoviruses, Virology, Humans -- Virus diseases, Mammals -- Virus diseases, Antiviral agents
Journal or Publication Title: mBio
Publisher: American Society for Microbiology
ISSN: 2150-7511
Official Date: 26 January 2016
Dates:
DateEvent
26 January 2016Published
22 December 2015Accepted
21 December 2015Submitted
Volume: 7
Number: 1
Article Number: e02184-15
DOI: 10.1128/mBio.02184-15
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 10 February 2016
Date of first compliant Open Access: 10 February 2016
Funder: National Institutes of Health (U.S.) (NIH), Wellcome Trust (London, England)
Grant number: CA122677 (NIH), AI007539 (NIH), WT094713MA

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us